New York Man Indicted in St. Louis, Accused of Selling Counterfeit Xanax on Dark Web
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • New York Man Indicted in St. Louis, Accused of Selling Counterfeit Xanax on Dark Web

New York Man Indicted in St. Louis, Accused of Selling Counterfeit Xanax on Dark Web

Abril 14, 2023
|
Share Article
|
Download Press Release
For Immediate Release
Contact:
Phone Number: (571) 362-5149

ST. LOUIS – A man from New York state has been indicted in federal court in St. Louis and accused of selling counterfeit Xanax on the dark web.

John Cruz, 29, of Rochester, New York, was indicted March 1 on one count of conspiracy to misbrand, introduce misbranded drugs and sell counterfeit drugs. He was arrested March 15 and appeared in U.S. District Court in St. Louis Friday by Zoom. He has pleaded not guilty to the charge.

The indictment alleges that using cryptocurrency, Cruz bought bulk quantities of counterfeit generic alprazolam, an anti-anxiety drug, from another person on the dark web who has sold millions of the pills. That person manufactured the pills using active drug ingredients from China, a pill press and stamps that would mimic the markings used on pills produced by manufacturers licensed and approved by the U.S. Food and Drug Administration. The pills were delivered to Cruz in Rochester, and he then redistributed the pills to various customers, the indictment alleges.

The charge is punishable by up to five years in prison, a $250,000 fine or both.

Charges set forth in an indictment are merely accusations and do not constitute proof of guilt.  Every defendant is presumed to be innocent unless and until proven guilty.

The Drug Enforcement Administration investigated this case with the FBI, the U.S. Postal Inspection Service and U.S. Immigration and Customs Enforcement.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Michael A. Davis Special Agent in Charge - St. Louis
@DEAStLouisDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster